Anne Armstrong
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 68
- PARP inhibition in cancer therapy 22
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 15
- Cancer Immunotherapy and Biomarkers 13
-
- Advanced Breast Cancer Therapies 34
- Co-authors
- Seock‐Ah Im (16 shared papers)Norikazu Masuda (17 shared papers)Binghe Xu (17 shared papers)Mark E. Robson (16 shared papers)Elżbieta Senkus (16 shared papers)Nadine Tung (16 shared papers)PierFranco Conte (16 shared papers)Suzette Delaloge (15 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Cancer Research (12 papers)Annals of Oncology (10 papers)European Journal of Cancer (6 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Anne Armstrong
112 papers receiving 5.2k citations
Anne Armstrong's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 3.1k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 1.2k
- Genetics 933
- Immunology 554
Countries citing papers authored by Anne Armstrong
This map shows the geographic impact of Anne Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Armstrong more than expected).
Fields of papers citing papers by Anne Armstrong
This network shows the impact of papers produced by Anne Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Armstrong. The network helps show where Anne Armstrong may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Armstrong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Hit paper breakdown → | 2017 | 2221 |
| 2 | OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Hit paper breakdown → | 2019 | 513 |
| 3 | Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study Hit paper breakdown → | 2018 | 482 |
| 4 | 2010 | 214 | |
| 5 | 2010 | 165 | |
| 6 | 2021 | 85 | |
| 7 | 2021 | 84 | |
| 8 | 2022 | 69 | |
| 9 | 2018 | 68 | |
| 10 | 2004 | 64 | |
| 11 | 2002 | 63 | |
| 12 | 2023 | 61 | |
| 13 | 2010 | 60 | |
| 14 | 2019 | 58 | |
| 15 | 2022 | 57 | |
| 16 | 2017 | 55 | |
| 17 | 2017 | 51 | |
| 18 | 2002 | 51 | |
| 19 | 2011 | 50 | |
| 20 | 2006 | 49 |
About Anne Armstrong
Anne Armstrong is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Cancer Research, having authored 120 papers that have together received 5.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (34 papers), PARP inhibition in cancer therapy (22 papers), Cancer Treatment and Pharmacology (17 papers), BRCA gene mutations in cancer (16 papers), HER2/EGFR in Cancer Research (15 papers), Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Breast Cancer Treatment Studies (7 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (1.0k citations), Pulmonary and Respiratory Medicine (1.2k citations), Genetics (933 citations) and Immunology (554 citations). Anne Armstrong has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Seock‐Ah Im, Norikazu Masuda, Binghe Xu, Mark E. Robson, Elżbieta Senkus, Nadine Tung, PierFranco Conte, Suzette Delaloge, Susan M. Domchek and Carsten Goessl. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.